Creo Medical Group Plc (CREO) Ord GBP0.001

- Add to watchlist
- Create an alert
- This stock can be held in a




9.75p
10.00p
37.20p
£40.22 million
9.75p
9.50p
9.30p
n/a
0.20p (2.09%) Previous:
0.20p
509,372
n/a
30,000
Performance
Not available for this stock.
Fundamental data
Year ending: | 31/12/2023 | 31/12/2022 |
---|---|---|
Revenue (£m) | 30.80 | 27.20 |
Profit before tax (£m) | (24.50) | (30.90) |
Adjusted EPS (p): | (7.00) | (14.48) |
P/E ratio | n/a | n/a |
PEG | n/a | n/a |
EPS growth (%) | n/a | n/a |
Values are quoted in the stock's local currency: British pound
All fundamental dataDividend information for this stock is not available.
Dividend information for this stock is not available.
Ready to invest?
Important Documents
There are no documents available for this stock.
-
Creo Medical eyes transition to full commercialisation in FY25
17 February 2025 08:00
-
Director dealings: Creo Medical chairman raises stake
16 December 2024 15:27
-
Creo Medical extends closing date for retail offer
4 October 2024 16:10
-
Notice of Results
15 April 2025 14:00
-
Holding(s) in Company
1 April 2025 09:34
-
Holding(s) in Company
31 March 2025 12:17
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.